Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03684538
Other study ID # 1022018
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 1, 2018
Est. completion date June 30, 2020

Study information

Verified date August 2022
Source Makassed General Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Background: Acute diarrhea in children is still a major health burden worldwide despite all efforts that have been made to reduce its incidence and prevalence. Children are more prone for dehydration that is the most common serious complication of acute diarrhea and can be easily avoided. Initiation of rehydration, early refeeding and giving suitable antimicrobial agents when indicated are the cornerstone for management. In addition, studies have emphasized on the role and efficacy of probiotics and zinc supplements on acute diarrhea in children. Indeed, there are a lot of studies on the role of zinc and probiotic in reducing the severity of acute diarrhea, but not many studies have compared effect of using a combination zinc with probiotics to zinc alone and probiotics alone on acute diarrhea. Objective:To compare the effectiveness of use of probiotics only, zinc only, and combination of zinc with probiotics on the duration and consistency of diarrhea in children presented for acute gastroenteritis. Methods: A total of 240 patients diagnosed with acute diarrhea will be divided into three groups each of 80 patients. The first group will be managed by addition of probiotics to standard treatment. The second group will be managed by addition of zinc to the standard treatment. The third group will be managed by the addition to a combination of zinc and probiotics to standard treatment. The patients will be followed to compare the effect of the given medication on the duration of diarrhea.


Description:

This is a prospective, randomized, double blinded, clinical trial that will be conducted on children presenting with acute diarrhea in Makassed General Hospital. Patient's level of dehydration will be assessed and a base line of frequency and consistency of diarrhea will be taken from parents'/ caregivers' history and observation. The consistency of stools will be scored according to the "Bristol Stool Chart". Also parents will be asked to sign an informed consent. A total of 240 eligible patients will be randomized by computer-generated numbers and the sealed envelope technique will be used to divide the patients into three groups. Group A will be composed of 80 patients. All of them will be given the standard of care (initiation of hydration and early refeeding, in addition to the use of antimicrobials in case a pathogen was identified). In addition to that, the patients in this group will receive probiotics (saccharomyces boulardii) one dose per day. Group B which will be composed of 80 patients. All of them will be given the standard of care (initiation of hydration and early refeeding, in addition to the use of antimicrobials in case a pathogen was identified). In addition to that, the patients in this group will receive zinc (10 mg for patients less than 6 month and 20 mg for older patients) one dose per day. Group C which will be composed of 80 patients. All of them will be given the standard of care (initiation of hydration and early refeeding, in addition to the use of antimicrobials in case a pathogen was identified). In addition to that, the patients in this group will receive a combination of probiotics (saccharomyces boulardii) with zinc (10 mg for patients less than 6 month and 20 mg for older patients) one dose per day. Upon assigning the group (A, B or C), the patient will receive his daily dose of medication in a sealed opaque tiny bag prepared by the nursing staff by adding 5 ml water to the assigned medication which will be unknown to both parent and researcher. Patients will be assessed on a daily basis. The quality and quantity of diarrhea, as well as hydration status, Po intake and parents satisfaction will be assessed daily until the end of illness, the length of stay for hospitalized patient will be also assessed.


Recruitment information / eligibility

Status Completed
Enrollment 240
Est. completion date June 30, 2020
Est. primary completion date June 30, 2020
Accepts healthy volunteers No
Gender All
Age group 31 Days to 5 Years
Eligibility Inclusion Criteria: - Acute diarrhea - Patients whose parents signed informed consent - Patients who have dehydration according to the World Health Organization (WHO) clinical scale Exclusion Criteria: - Severe dehydration - Coexisting severe infection (e.g. sepsis, pneumonia, meningitis) - Immune deficiency - Patients whose parents refuse to provide written informed consent - Patients who do not comply with treatment

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Probiotics
Patients will receive probiotics (Saccharomyces boulardii) one dose per day (250 mg)
Zinc
Patients will receive zinc (10 mg for patients less than 6 month and 20 mg for older patients) one dose per day
Probiotics & Zinc
Patients will receive a combination of probiotics (Saccharomyces boulardii 250 mg) with zinc (10 mg for patients less than 6 month and 20 mg for older patients) one dose per day
Standard care
initiation of hydration and early refeeding, in addition to the use of antimicrobials in case a pathogen was identified

Locations

Country Name City State
Lebanon Makassed General Hospital Beirut

Sponsors (1)

Lead Sponsor Collaborator
Makassed General Hospital

Country where clinical trial is conducted

Lebanon, 

Outcome

Type Measure Description Time frame Safety issue
Primary Diarrhea consistency consistency of diarrhea scored according to the "Bristol Stool Chart" Till the end of diarrhea, an average of five days
Secondary Diarrhea duration duration of diarrhea in days Till the end of diarrhea, an average of five days
Secondary Hospital stay Length of hospital stay in days Till the end of diarrhea, an average of four days
See also
  Status Clinical Trial Phase
Completed NCT04039828 - Zinc Sulfate Acceptability N/A
Completed NCT03943654 - Improving Nighttime Access to Care and Treatment (Part 2)
Completed NCT01577043 - Efficacy of Racecadotril in Acute Watery Diarrhea in Children Phase 4
Not yet recruiting NCT03598010 - Safety, Tolerability and Preliminary Efficacy of Lenodiar Pediatric in Diarrhea N/A
Terminated NCT02817165 - Probiotics for the Prevention of Antibiotic-Associated Diarrhea N/A
Completed NCT04237181 - Results of FilmArray® Gastro-intestinal Panel and Serum Procalcitonin in Acute Colitis and Infectious Diarrhea in the ER N/A
Completed NCT05345028 - Boswellia Serrata Extract in Acute Diarrhea N/A
Completed NCT01814202 - Study With Medical Nutrition Product PTM202 in Pediatric Diarrhea N/A
Completed NCT02896465 - Human Milk Oligosaccharides and Childhood Diarrhoea N/A
Completed NCT01927094 - Effects of Probiotics and/or Prebiotics on the Duration of Diarrhea and Hospitalization in Children Phase 4
Completed NCT04796480 - Comparison Of Outcome Of Lactose Free Formula Milk With Yogurt In Children With Acute Diarrhea N/A
Completed NCT01571856 - Efficacy of Use of Zinc in the Treatment of Acute Diarrhea in Infants Phase 4
Completed NCT01269892 - Early Administration of Lactose-free Milk in Children Presenting With Acute Diarrhea Phase 2
Completed NCT00429325 - Fecal Calprotectin: Cheap Marker for Diagnosing Acute Infectious Diarrhea N/A
Recruiting NCT05183789 - IL6&8 in Malnourished Children With Acute Diarrhea
Completed NCT01564290 - Use of Probiotic Yogurt in the Treatment of Acute Diarrhea in Children Phase 4
Recruiting NCT05213325 - Evaluation of Serum Interleukin 6 and 8 in Children With Acute Gastroenteritis
Unknown status NCT01273012 - Cost-effectiveness of Infloran (TM) in Treating Acute Childhood Diarrhea in Phramongkutklao Hospital N/A
Completed NCT03356327 - Oral Administration of Tannins and Flavonoids in Children With Acute Diarrhea Phase 4